MARKET

HCM

HCM

Hutchmed (China) Limited
NASDAQ
11.92
-0.14
-1.16%
Opening 15:07 05/20 EDT
OPEN
11.92
PREV CLOSE
12.06
HIGH
12.01
LOW
11.84
VOLUME
12.84K
TURNOVER
--
52 WEEK HIGH
19.50
52 WEEK LOW
11.83
MARKET CAP
2.08B
P/E (TTM)
4.554
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at HCM last week (0511-0515)?
Weekly Report · 2d ago
HUTCHMED files directors list with Hong Kong Stock Exchange
PUBT · 05/13 08:38
Weekly Report: what happened at HCM last week (0504-0508)?
Weekly Report · 05/11 10:09
Weekly Report: what happened at HCM last week (0427-0501)?
Weekly Report · 05/04 10:07
Hutchmed says NDA for sovleplenib accepted in China
TipRanks · 04/29 10:46
HUTCHMED says China NMPA accepts sovleplenib wAIHA NDA for priority review
PUBT · 04/29 10:08
China Authority Accepts And Grants Priority Review To Hutchmed's Sovleplenib For Warm Antibody Autoimmune Hemolytic Anemia Patients Who Have Had An Insufficient Response To Prior Glucocorticoid Treatment
Benzinga · 04/29 10:08
HUTCHMED Announces NDA Acceptance in China with Priority Review Status and Breakthrough Designation for Sovleplenib for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia
Barchart · 04/29 05:00
More
About HCM
HUTCHMED (China) Ltd is an investment holding company principally engaged in the manufacture and sale of pharmaceuticals. The Company operates its business through two segments. Oncology Immunology segment is engaged in the discovery, development and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. Among it, research and development (R&D) includes research and development activities covering drug discovery, development, manufacturing and regulatory functions, out-licensing of in-house developed drugs, as well as administrative activities to support research and development operations, marketed products comprises the invoiced sales, marketing, manufacture and distribution of drugs developed from research and development activities. Other Ventures segment is engaged in the other commercial businesses which include the sales, marketing, manufacture and distribution of other prescription drugs and healthcare products.

Webull offers HUTCHMED (China) Ltd (ADR) stock information, including NASDAQ: HCM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HCM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading HCM stock methods without spending real money on the virtual paper trading platform.